{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T02:13:18Z","timestamp":1783476798482,"version":"3.55.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100013072","name":"Major Science and Technology Project of Hainan Province","doi-asserted-by":"publisher","award":["WSJK2024MS163"],"award-info":[{"award-number":["WSJK2024MS163"]}],"id":[{"id":"10.13039\/501100013072","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82200169"],"award-info":[{"award-number":["82200169"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-03846-9","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T14:47:23Z","timestamp":1764082043000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Overexpression of Sterol Regulatory Element-binding Transcription Factor 2 is associated with an adverse prognosis in cytogenetically normal acute myeloid leukemia"],"prefix":"10.1007","volume":"16","author":[{"given":"Ruoqi","family":"Shan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiachi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoling","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujun","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaowei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sai","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,25]]},"reference":[{"issue":"8","key":"3846_CR1","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1158\/1535-7163.MCT-18-1125","volume":"18","author":"D Papaioannou","year":"2019","unstructured":"Papaioannou D, Nicolet D, Ozer HG, et al. Prognostic and biologic relevance of clinically applicable long noncoding RNA profiling in older patients with cytogenetically normal acute myeloid leukemia. Mol Cancer Ther. 2019;18(8):1451\u20139. https:\/\/doi.org\/10.1158\/1535-7163.MCT-18-1125.","journal-title":"Mol Cancer Ther"},{"issue":"4","key":"3846_CR2","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1182\/blood-2016-08-733196","volume":"129","author":"H D\u00f6hner","year":"2017","unstructured":"D\u00f6hner H, Estey E, Grimwade D, et al. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood. 2017;129(4):424\u201347. https:\/\/doi.org\/10.1182\/blood-2016-08-733196.","journal-title":"Blood"},{"issue":"21","key":"3846_CR3","doi-asserted-by":"publisher","first-page":"6524","DOI":"10.1158\/1078-0432.CCR-19-0725","volume":"25","author":"CJ Walker","year":"2019","unstructured":"Walker CJ, Kohlschmidt J, Eisfeld AK, et al. Genetic characterization and prognostic relevance of acquired uniparental disomies in cytogenetically normal acute myeloid leukemia. Clin Cancer Res. 2019;25(21):6524\u201331. https:\/\/doi.org\/10.1158\/1078-0432.CCR-19-0725.","journal-title":"Clin Cancer Res"},{"issue":"5","key":"3846_CR4","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1182\/blood-2016-01-693879","volume":"128","author":"KH Metzeler","year":"2016","unstructured":"Metzeler KH, Herold T, Rothenberg-Thurley M, et al. Spectrum and prognostic relevance of driver gene mutations in acute myeloid leukemia. Blood. 2016;128(5):686\u201398. https:\/\/doi.org\/10.1182\/blood-2016-01-693879.","journal-title":"Blood"},{"issue":"2","key":"3846_CR5","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1097\/MOH.0000000000000853","volume":"32","author":"C O\u2019Brien","year":"2025","unstructured":"O\u2019Brien C, Jones CL. Unraveling lipid metabolism for acute myeloid leukemia therapy. Curr Opin Hematol. 2025;32(2):77\u201386. https:\/\/doi.org\/10.1097\/MOH.0000000000000853.","journal-title":"Curr Opin Hematol"},{"issue":"8","key":"3846_CR6","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1038\/s41375-025-02645-z","volume":"39","author":"V Dembitz","year":"2025","unstructured":"Dembitz V, James SC, Gallipoli P. Targeting lipid metabolism in acute myeloid leukemia: biological insights and therapeutic opportunities. Leukemia. 2025;39(8):1814\u201323. https:\/\/doi.org\/10.1038\/s41375-025-02645-z.","journal-title":"Leukemia"},{"key":"3846_CR7","unstructured":"SREBP-regulated lipid metabolism: convergent physiology - divergent pathophysiology . 2024."},{"key":"3846_CR8","unstructured":"Fatostatin displays high antitumor activity in prostate cancer by blocking SREBP-regulated metabolic pathways and androgen receptor signaling. 2024."},{"issue":"17","key":"3846_CR9","doi-asserted-by":"publisher","first-page":"4772","DOI":"10.1158\/0008-5472.CAN-14-0130","volume":"74","author":"A Pandyra","year":"2014","unstructured":"Pandyra A, Mullen PJ, Kalkat M, et al. Immediate utility of two approved agents to target both the metabolic mevalonate pathway and its restorative feedback loop. Cancer Res. 2014;74(17):4772\u201382. https:\/\/doi.org\/10.1158\/0008-5472.CAN-14-0130.","journal-title":"Cancer Res"},{"issue":"1","key":"3846_CR10","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3324\/haematol.13299","volume":"94","author":"RGW Verhaak","year":"2009","unstructured":"Verhaak RGW, Wouters BJ, Erpelinck CAJ, et al. Prediction of molecular subtypes in acute myeloid leukemia based on gene expression profiling. Haematologica. 2009;94(1):131\u20134. https:\/\/doi.org\/10.3324\/haematol.13299.","journal-title":"Haematologica"},{"key":"3846_CR11","unstructured":"NCBI GEO: archive for functional genomics data sets\u2013update. 2024."},{"issue":"1","key":"3846_CR12","doi-asserted-by":"publisher","first-page":"9115","DOI":"10.1038\/s41598-024-59464-y","volume":"14","author":"J Wang","year":"2024","unstructured":"Wang J, Wang H, Ding Y, Jiao X, Zhu J, Zhai Z. NET-related gene signature for predicting AML prognosis. Sci Rep. 2024;14(1):9115. https:\/\/doi.org\/10.1038\/s41598-024-59464-y.","journal-title":"Sci Rep"},{"key":"3846_CR13","doi-asserted-by":"publisher","first-page":"1131159","DOI":"10.3389\/fgene.2023.1131159","volume":"14","author":"N Eshibona","year":"2023","unstructured":"Eshibona N, Livesey M, Christoffels A, Bendou H. Investigation of distinct gene expression profile patterns that can improve the classification of intermediate-risk prognosis in AML patients. Front Genet. 2023;14:1131159. https:\/\/doi.org\/10.3389\/fgene.2023.1131159.","journal-title":"Front Genet"},{"issue":"16","key":"3846_CR14","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1056\/NEJMoa040465","volume":"350","author":"PJM Valk","year":"2004","unstructured":"Valk PJM, Verhaak RGW, Beijen MA, et al. Prognostically useful gene-expression profiles in acute myeloid leukemia. N Engl J Med. 2004;350(16):1617\u201328. https:\/\/doi.org\/10.1056\/NEJMoa040465.","journal-title":"N Engl J Med"},{"issue":"6","key":"3846_CR15","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/j.cell.2019.01.031","volume":"176","author":"P van Galen","year":"2019","unstructured":"van Galen P, Hovestadt V, Wadsworth Ii MH, et al. Single-Cell RNA-Seq reveals AML hierarchies relevant to disease progression and immunity. Cell. 2019;176(6):1265\u2013e128124. https:\/\/doi.org\/10.1016\/j.cell.2019.01.031.","journal-title":"Cell"},{"issue":"3","key":"3846_CR16","doi-asserted-by":"publisher","first-page":"dju494","DOI":"10.1093\/jnci\/dju494","volume":"107","author":"D Hanniford","year":"2015","unstructured":"Hanniford D, Segura MF, Zhong J, et al. Identification of metastasis-suppressive MicroRNAs in primary melanoma. J Natl Cancer Inst. 2015;107(3):dju494. https:\/\/doi.org\/10.1093\/jnci\/dju494.","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"3846_CR17","doi-asserted-by":"publisher","first-page":"3445","DOI":"10.1038\/s41467-021-23774-w","volume":"12","author":"T Wang","year":"2021","unstructured":"Wang T, Shao W, Huang Z, et al. MOGONET integrates multi-omics data using graph convolutional networks allowing patient classification and biomarker identification. Nat Commun. 2021;12(1):3445. https:\/\/doi.org\/10.1038\/s41467-021-23774-w.","journal-title":"Nat Commun"},{"key":"3846_CR18","doi-asserted-by":"publisher","unstructured":"Chen J, Bardes EE, Aronow BJ, Jegga AG. ToppGene suite for gene list enrichment analysis and candidate gene prioritization. Nucleic Acids Res. 2009;W305\u2013311. https:\/\/doi.org\/10.1093\/nar\/gkp427. 37","DOI":"10.1093\/nar\/gkp427"},{"issue":"2","key":"3846_CR19","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s13577-019-00319-4","volume":"33","author":"F Wu","year":"2020","unstructured":"Wu F, Yin C, Qi J, et al. miR-362-5p promotes cell proliferation and cell cycle progression by targeting GAS7 in acute myeloid leukemia. Hum Cell. 2020;33(2):405\u201315. https:\/\/doi.org\/10.1007\/s13577-019-00319-4.","journal-title":"Hum Cell"},{"key":"3846_CR20","unstructured":"Genomic analysis of biomarkers related to the prognosis of acute myeloid leukemia . 2024."},{"key":"3846_CR21","unstructured":"MiR-362-5p as a novel prognostic predictor of cytogenetically normal acute myeloid leukemia - PubMed. Accessed September 21. 2024."},{"key":"3846_CR22","unstructured":"Increased Expression of Micro-RNA-23a Mediates Chemoresistance to Cytarabine in Acute Myeloid Leukemia. 2024."},{"issue":"5","key":"3846_CR23","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1038\/s41388-021-02127-3","volume":"41","author":"AP Singh","year":"2022","unstructured":"Singh AP, Luo H, Matur M, et al. A coordinated function of LncRNA HOTTIP and miRNA-196b underpinning leukemogenesis by targeting FAS signaling. Oncogene. 2022;41(5):718\u201331. https:\/\/doi.org\/10.1038\/s41388-021-02127-3.","journal-title":"Oncogene"},{"key":"3846_CR24","unstructured":"MicroRNA expression at diagnosis. adds relevant prognostic information to molecular categorization in patients with intermediate-risk cytogenetic acute myeloid leukemia - PubMed. 2024."},{"key":"3846_CR25","unstructured":"High level of. miR-196b at newly diagnosed pediatric acute myeloid leukemia predicts a poor outcome. 2024."},{"issue":"3","key":"3846_CR26","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1111\/j.1549-8719.2011.00153.x","volume":"19","author":"C Bang","year":"2012","unstructured":"Bang C, Fiedler J, Thum T. Cardiovascular importance of the microRNA-23\/27\/24 family. Microcirculation. 2012;19(3):208\u201314. https:\/\/doi.org\/10.1111\/j.1549-8719.2011.00153.x.","journal-title":"Microcirculation"},{"issue":"4","key":"3846_CR27","doi-asserted-by":"publisher","first-page":"648","DOI":"10.4161\/rna.8.4.15583","volume":"8","author":"R Chhabra","year":"2011","unstructured":"Chhabra R, Dubey R, Saini N. Gene expression profiling indicate role of ER stress in miR-23a\u2009~\u200927a\u2009~\u200924\u2009\u2013\u20092 cluster induced apoptosis in HEK293T cells. RNA Biol. 2011;8(4):648\u201364. https:\/\/doi.org\/10.4161\/rna.8.4.15583.","journal-title":"RNA Biol"},{"key":"3846_CR28","unstructured":"miR-23\u223c27\u223c24 clusters control effector T cell differentiation and function. 2024."},{"key":"3846_CR29","unstructured":"Endogenous Tumor Suppressor microRNA-193b: Therapeutic and Prognostic Value in Acute Myeloid Leukemia. 2024."},{"key":"3846_CR30","doi-asserted-by":"publisher","first-page":"439","DOI":"10.3389\/fphar.2016.00439","volume":"7","author":"DD Xu","year":"2016","unstructured":"Xu DD, Zhou PJ, Wang Y, et al. miR-150 suppresses the proliferation and tumorigenicity of leukemia stem cells by targeting the Nanog signaling pathway. Front Pharmacol. 2016;7:439. https:\/\/doi.org\/10.3389\/fphar.2016.00439.","journal-title":"Front Pharmacol"},{"key":"3846_CR31","unstructured":"Loss of miR-31-5p drives hematopoietic stem cell malignant transformation and restoration eliminates leukemia stem cells in mice. 2024."},{"issue":"10","key":"3846_CR32","doi-asserted-by":"publisher","first-page":"753","DOI":"10.3760\/cma.j.issn.0253-3766.2019.10.006","volume":"41","author":"YS Zhang","year":"2019","unstructured":"Zhang YS, Wang MY, Zhang WL, Tang CH. [Proliferation, migration and apoptosis of acute myeloid leukemia cells regulated by mir-23a-3p targeting SMC1A and the mechanism]. Zhonghua Zhong Liu Za Zhi. 2019;41(10):753\u20139. https:\/\/doi.org\/10.3760\/cma.j.issn.0253-3766.2019.10.006.","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"issue":"1","key":"3846_CR33","doi-asserted-by":"publisher","first-page":"77","DOI":"10.7150\/thno.77404","volume":"13","author":"S Ye","year":"2023","unstructured":"Ye S, Xiong F, He X, et al. DNA hypermethylation-induced miR-182 silence targets BCL2 and HOXA9 to facilitate the self-renewal of leukemia stem cell, accelerate acute myeloid leukemia progression, and determine the sensitivity of BCL2 inhibitor venetoclax. Theranostics. 2023;13(1):77\u201394. https:\/\/doi.org\/10.7150\/thno.77404.","journal-title":"Theranostics"},{"issue":"1","key":"3846_CR34","doi-asserted-by":"publisher","first-page":"3671","DOI":"10.1080\/21691401.2019.1596930","volume":"47","author":"H Wang","year":"2019","unstructured":"Wang H, He H, Yang C. miR-342 suppresses the proliferation and invasion of acute myeloid leukemia by targeting Naa10p. Artif Cells Nanomed Biotechnol. 2019;47(1):3671\u20136. https:\/\/doi.org\/10.1080\/21691401.2019.1596930.","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"3846_CR35","unstructured":"The SREBP. pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. 2024."},{"issue":"2","key":"3846_CR36","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1182\/blood.2021012788","volume":"139","author":"A Brendolan","year":"2022","unstructured":"Brendolan A, Russo V. Targeting cholesterol homeostasis in hematopoietic malignancies. Blood. 2022;139(2):165\u201376. https:\/\/doi.org\/10.1182\/blood.2021012788.","journal-title":"Blood"},{"issue":"5","key":"3846_CR37","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.immuni.2018.08.021","volume":"49","author":"C Guo","year":"2018","unstructured":"Guo C, Chi Z, Jiang D, et al. Cholesterol homeostatic regulator SCAP-SREBP2 integrates NLRP3 inflammasome activation and cholesterol biosynthetic signaling in macrophages. Immunity. 2018;49(5):842\u2013e8567. https:\/\/doi.org\/10.1016\/j.immuni.2018.08.021.","journal-title":"Immunity"},{"issue":"6","key":"3846_CR38","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1002\/hep.29018","volume":"65","author":"N Li","year":"2017","unstructured":"Li N, Zhou ZS, Shen Y, et al. Inhibition of the sterol regulatory element-binding protein pathway suppresses hepatocellular carcinoma by repressing inflammation in mice. Hepatology. 2017;65(6):1936\u201347. https:\/\/doi.org\/10.1002\/hep.29018.","journal-title":"Hepatology"},{"issue":"13","key":"3846_CR39","doi-asserted-by":"publisher","first-page":"6560","DOI":"10.7150\/thno.55609","volume":"11","author":"KL Zhang","year":"2021","unstructured":"Zhang KL, Zhu WW, Wang SH, et al. Organ-specific cholesterol metabolic aberration fuels liver metastasis of colorectal cancer. Theranostics. 2021;11(13):6560\u201372. https:\/\/doi.org\/10.7150\/thno.55609.","journal-title":"Theranostics"},{"issue":"2","key":"3846_CR40","doi-asserted-by":"publisher","first-page":"354","DOI":"10.3390\/cells9020354","volume":"9","author":"S Fazio","year":"2020","unstructured":"Fazio S, Berti G, Russo F, et al. The miR-28-5p targetome discovery identified SREBF2 as one of the mediators of the miR-28-5p tumor suppressor activity in prostate cancer cells. Cells. 2020;9(2):354. https:\/\/doi.org\/10.3390\/cells9020354.","journal-title":"Cells"},{"issue":"1","key":"3846_CR41","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1038\/s41467-019-09116-x","volume":"10","author":"SE Syafruddin","year":"2019","unstructured":"Syafruddin SE, Rodrigues P, Vojtasova E, et al. A KLF6-driven transcriptional network links lipid homeostasis and tumour growth in renal carcinoma. Nat Commun. 2019;10(1):1152. https:\/\/doi.org\/10.1038\/s41467-019-09116-x.","journal-title":"Nat Commun"},{"issue":"4","key":"3846_CR42","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/s41388-023-02903-3","volume":"43","author":"E Erkner","year":"2024","unstructured":"Erkner E, Hentrich T, Schairer R, et al. The ROR\u0263\/SREBP2 pathway is a master regulator of cholesterol metabolism and serves as potential therapeutic target in t(4;11) leukemia. Oncogene. 2024;43(4):281\u201393. https:\/\/doi.org\/10.1038\/s41388-023-02903-3.","journal-title":"Oncogene"},{"issue":"1","key":"3846_CR43","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13045-017-0409-z","volume":"10","author":"Y Li","year":"2017","unstructured":"Li Y, Xu Q, Lv N, et al. Clinical implications of genome-wide DNA methylation studies in acute myeloid leukemia. J Hematol Oncol. 2017;10(1):41. https:\/\/doi.org\/10.1186\/s13045-017-0409-z.","journal-title":"J Hematol Oncol"},{"issue":"2","key":"3846_CR44","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/s41416-020-01117-8","volume":"124","author":"TM Barrow","year":"2021","unstructured":"Barrow TM, Nakjang S, Lafta F, et al. Epigenome-wide analysis reveals functional modulators of drug sensitivity and post-treatment survival in chronic lymphocytic leukaemia. Br J Cancer. 2021;124(2):474\u201383. https:\/\/doi.org\/10.1038\/s41416-020-01117-8.","journal-title":"Br J Cancer"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03846-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-03846-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03846-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T00:02:57Z","timestamp":1764374577000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-03846-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,25]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3846"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-03846-9","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,25]]},"assertion":[{"value":"29 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study received approval from the relevant local institutional review boards. In compliance with the Helsinki Declaration, all participants furnished written informed consent (further information can be found at\n                      \n                      ).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2182"}}